Research
Read how they describe their research on their Queen's University profile.
Latest papers
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expression.
Therapeutic advances in hematology · 2026
Evaluation of early prophylactic corticosteroid administration on early safety and efficacy outcomes of adeno-associated virus gene therapy in the hemophilia dog model.
Journal of thrombosis and haemostasis : JTH · 2026 · first author
Adeno-associated viral vector integration: implications for long-term efficacy and safety.
Journal of thrombosis and haemostasis : JTH · 2024 · first author
10 publications.
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expression.
Fong S, Swystun LL, Batty P, Lillicrap D
Evaluation of early prophylactic corticosteroid administration on early safety and efficacy outcomes of adeno-associated virus gene therapy in the hemophilia dog model.
Batty P, Swystun LL, Handyside B, Menard A, Harpell L, Hurlbut D, Ismail AM, Mo A, Pender A, Brennan S, Winterborn A, Yates B, Fong S, Lillicrap D
Adeno-associated viral vector integration: implications for long-term efficacy and safety.
Batty P, Lillicrap D
Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer.
Batty P, Fong S, Franco M, Sihn CR, Swystun LL, Afzal S, Harpell L, Hurlbut D, Pender A, Su C, Thomsen H, Wilson C, Youssar L, Winterborn A, Gil-Farina I, Lillicrap D
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A.
Strilchuk AW, Hur WS, Batty P, Sang Y, Abrahams SR, Yong ASM, Leung J, Silva LM, Schroeder JA, Nesbitt K, de Laat B, Moutsopoulos NM, Bugge TH, Shi Q, Cullis PR, Merricks EP, Wolberg AS, Flick MJ, Lillicrap D, Nichols TC, Kastrup CJ
Application of in-vitro-cultured primary hepatocytes to evaluate species translatability and AAV transduction mechanisms of action.
Liu S, Razon L, Ritchie O, Sihn CR, Handyside B, Berguig G, Woloszynek J, Zhang L, Batty P, Lillicrap D, Agrawal V, Cortesio C, Gebretsadik K, Akeefe H, Colosi P, Kim B, Bunting S, Fong S
Hemophilia Gene Therapy: Approaching the First Licensed Product.
Batty P, Lillicrap D
Gene therapy for hemophilia: Current status and laboratory consequences.
Batty P, Lillicrap D
Advances in knowledge of inhibitor formation in severe haemophilia A.
Cormier M, Batty P, Tarrant J, Lillicrap D
Advances and challenges for hemophilia gene therapy.
Batty P, Lillicrap D
Frequent collaborators
- Pieter Cullis and Christian Kastrup: 16 shared papers
- David Lillicrap and Paul Batty: 10 shared papers
- David Lillicrap and Sylvia Fong: 3 shared papers
- David Lillicrap and Julie Tarrant: 3 shared papers
- Paul Batty and Sylvia Fong: 3 shared papers
- David Lillicrap and Christian Kastrup: 2 shared papers
- David Lillicrap and David Hurlbut: 2 shared papers
- Paul Batty and David Hurlbut: 2 shared papers
- Sylvia Fong and David Hurlbut: 2 shared papers
- Pieter Cullis and David Lillicrap: 1 shared paper
- Pieter Cullis and Paul Batty: 1 shared paper
- Christian Kastrup and Paul Batty: 1 shared paper
- Paul Batty and Julie Tarrant: 1 shared paper
- Pathology
- Department of Medicine
- Michael Smith Laboratories
- Biochemistry
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
David Lillicrap
Department of Medicine
10 shared papers, latest 2026
Sylvia Fong
Pathology
3 shared papers, latest 2026
David Hurlbut
Pathology
2 shared papers, latest 2026
Julie Tarrant
Pathology
1 shared papers, latest 2020
Pieter Cullis
Biochemistry
1 shared papers, latest 2024
Christian Kastrup
Michael Smith Laboratories
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.